| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |